U.S. Food and Drug Administration (FDA) recently accepted the Biologics License Application (BLA) for RP1 plus nivolumab in advanced melanoma for ...

The AICPA had urged the SEC to refrain from approving the rules, warning they would “pose significant challenges” to small and midsize firms. An AICPA statement said that the “PCAOB’s decision not to ...

Birchcliff Energy Ltd. (“Birchcliff” or the “Corporation”) (TSX: BIR) is pleased to announce its unaudited 2024 full-year and fourth quarter financial and operational results and highlights from its ...

Q2 2025 Earnings Conference Call February 12, 2025 5:00 PM ETCompany ParticipantsLincoln Tan - Director of IRDaniel Roberts ...

Merrill projected accelerated revenue growth in the second half of fiscal 2025, targeting an annual growth rate of 10%-20%. He explained that traceability alone could contribute $10M in incremental ...

New legislation in Virginia helps improve long-term earnings predictability but comes with lower allowed returns on equity for the next two years. The legislation only brings clarity for investors for ...

Objective To test the hypothesis that gouty arthritis (gout) is a risk factor for incidence of heart failure and for echocardiographic measures signifying subclinical heart failure. Design Post-hoc, ...